Your trusted source for investing success

Tag: FDA

Looking for Cannabis Stocks?


Read our report to find market data, important news and stocks to watch!


Arimoclomol for NPC receives Rare Pediatric Disease Designation

Orphazyme A/S, a Danish biotech company (ORPHA:CO), with a late-stage, orphan-drug pipeline, today announced that arimoclomol has been granted rare pediatric disease designation by the US Food and Drug Administration (FDA) for the treatment of Niemann-Pick disease Type C.

As quoted in the press release:
NPC is a genetic disease affecting around

Obalon Therapeutics Prices Public Offering of Common Stock

Obalon Therapeutics (NASDAQ:OBLN), a vertically integrated medical device company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announced the pricing of an underwritten public offering of 5,454,545 shares of its common stock at a public offering price of $5.50 per share.

As quoted

Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations

Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has partnered with Mr. Charles (Chuck) Austin and JK Advisors in order to scale up operational

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Cannabis Weekly Round-Up: Newstrike Recovers After Dip from Acquisition Voting Results

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/cannabis-weekly-roundup/